Invest Hong Kong (InvestHK) and the Hong Kong Economic and Trade Office (Tokyo) jointly organised a business mission comprising 13 delegates from Japanese medical and life science companies to visit Hong Kong from May 25 to 28 to understand Hong Kong's healthcare market and explore business opportunities in Hong Kong.
 
     This is the fourth sector-specific business mission organised by InvestHK and the Hong Kong Economic and Trade Office (Tokyo) in recent years, following the last innovation and technology mission in May 2024, and two food and beverage missions, which were held in February 2025 and April 2023 respectively.
 
     Tying in with the Hong Kong Trade Development Council's Asia Summit on Global Health and the Hong Kong International Medical and Healthcare Fair 2025, on May 26 and 27, the delegation attended a series of visits, themed seminars, networking sessions, as well as business matching meetings with potential investors, investees and business partners.
 
     At the welcome dinner held on May 26, the Director-General of Investment Promotion, Ms Alpha Lau, said, "With the highest life expectancy in the world, Hong Kong has proven itself as a hub of healthcare excellence and technological innovation. Home to two of the world's top 30 medical schools, a first-class research talent pool, and globally recognised clinical trial data, our city is a powerhouse for biotech advancement."
 
     On May 27, the delegates visited the Hong Kong Science and Technology Parks Corporation (HKSTP) to attend a briefing session on the business environment and opportunities available in Hong Kong, followed by a tour of the HKSTP's Japanese tenants’ lab and other facilities. The delegates then attended a networking dinner organised by InvestHK.

Ends/Friday, May 30, 2025
Issued at HKT 14:45

NNNN